ATE352641T1 - Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs - Google Patents

Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs

Info

Publication number
ATE352641T1
ATE352641T1 AT02710132T AT02710132T ATE352641T1 AT E352641 T1 ATE352641 T1 AT E352641T1 AT 02710132 T AT02710132 T AT 02710132T AT 02710132 T AT02710132 T AT 02710132T AT E352641 T1 ATE352641 T1 AT E352641T1
Authority
AT
Austria
Prior art keywords
serum
gastric cancer
epstein
circulation
cancer patients
Prior art date
Application number
AT02710132T
Other languages
English (en)
Inventor
Yuk Ming Dennis Lo
Wing Yee Chan
Kwok Wai Ng
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Application granted granted Critical
Publication of ATE352641T1 publication Critical patent/ATE352641T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT02710132T 2001-01-31 2002-01-30 Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs ATE352641T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26556801P 2001-01-31 2001-01-31

Publications (1)

Publication Number Publication Date
ATE352641T1 true ATE352641T1 (de) 2007-02-15

Family

ID=23010993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02710132T ATE352641T1 (de) 2001-01-31 2002-01-30 Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs

Country Status (7)

Country Link
US (2) US6753137B2 (de)
EP (1) EP1356124B1 (de)
JP (1) JP2004536282A (de)
CN (1) CN1272448C (de)
AT (1) ATE352641T1 (de)
DE (1) DE60217823D1 (de)
WO (1) WO2002061148A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228575A1 (en) * 2001-01-31 2003-12-11 Yuk Ming Dennis Lo Combination of circulating epstein-barr virus (EBV) DNA in the serum or plasma of patients and a method to assess EBV subtypes for the prediction and detection of epstein-barr virus associated cancers
EP1528107B1 (de) * 2003-10-29 2006-11-22 Maurice Stroun Verfahren zur Diagnose von Krebs
JP4182227B2 (ja) * 2005-09-09 2008-11-19 国立大学法人 岡山大学 ウイルス潜伏感染の検査方法および検査用キット
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US7842482B2 (en) * 2007-02-26 2010-11-30 The Chinese University Of Hong Kong Methods and kits for diagnosis, prognosis or monitoring of Epstein-Barr virus (EBV)-associated cancer
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
DK2496720T3 (da) 2009-11-06 2020-09-28 Univ Leland Stanford Junior Ikke-invasiv diagnose af transplantatafstødning i organ-transplanterede patienter
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
CA3069089A1 (en) * 2011-09-22 2013-03-28 Lineage Biosciences, Inc. Compositions and methods for analyzing heterogeneous samples
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP2970959B1 (de) 2013-03-15 2018-05-30 Lineage Biosciences, Inc. Verfahren und zusammensetzungen zum markieren und analysieren von proben
KR102205950B1 (ko) 2013-11-07 2021-01-22 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 인간 마이크로바이옴 및 그의 성분의 분석을 위한 무세포 핵산
CN103642945B (zh) * 2013-12-30 2019-01-08 上海星耀医学科技发展有限公司 一种含内参照的高灵敏Epstein-Barr病毒荧光定量PCR试剂盒
EP4428251A3 (de) 2014-09-11 2024-12-18 Immunis.AI, Inc. Verfahren zum nachweis von prostatakrebs
CN104604799B (zh) * 2015-02-05 2017-11-21 南华大学 一种鉴定eb病毒对淋巴瘤的诱发性的方法
EP3298169B1 (de) 2015-05-18 2024-10-02 Karius, Inc. Zusammensetzungen und verfahren zur anreicherung von populationen von nukleinsäuren
KR102326769B1 (ko) 2016-03-25 2021-11-17 카리우스, 인코포레이티드 합성 핵산 스파이크-인
CA3059370C (en) 2017-04-12 2022-05-10 Karius, Inc. Methods for concurrent analysis of dna and rna in mixed samples
RU2659134C1 (ru) * 2017-09-20 2018-06-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Смоленский государственный медицинский университет" министерства здравоохранения Российской Федерации Способ оценки степени тяжести течения хронического эрозивного гастрита, ассоциированного с helicobacter pylori и вирусом эпшейн-барр
JP7239973B2 (ja) * 2017-12-19 2023-03-15 国立大学法人山口大学 前癌病変又は癌の有無の予測を補助する方法
CA3082601A1 (en) 2018-03-16 2019-09-19 Karius, Inc. Sample series to differentiate target nucleic acids from contaminant nucleic acids
WO2019232436A1 (en) * 2018-06-01 2019-12-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Gamma herpesvirus circular rna
CA3106975A1 (en) 2018-08-01 2020-02-06 Gen-Probe Incorporated Compositions and methods for detecting nucleic acids of epstein-barr virus
CN109022619A (zh) * 2018-08-27 2018-12-18 郑州安图生物工程股份有限公司 一种用于检测人类疱疹病毒4型的试剂盒
EP4700161A3 (de) 2018-11-21 2026-03-11 Karius, Inc. Direct-to-library-methoden, systeme und zusammensetzungen
JP7649285B2 (ja) * 2019-07-25 2025-03-19 エフ. ホフマン-ラ ロシュ アーゲー エプスタイン・バーウイルス(ebv)を検出するための組成物および方法
US12618839B2 (en) 2019-10-24 2026-05-05 Arizona Board Of Regents On Behalf Of Arizona State University Antibodies for detecting Epstein Barr virus-positive gastric cancer
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
WO2025216320A1 (ja) * 2024-04-12 2025-10-16 国立大学法人熊本大学 牛伝染性リンパ腫の病勢の検査方法、プライマー、cfDNA定量キット、及び牛伝染性リンパ腫の病勢の検査キット

Also Published As

Publication number Publication date
CN1489634A (zh) 2004-04-14
EP1356124A2 (de) 2003-10-29
HK1061048A1 (en) 2004-09-03
JP2004536282A (ja) 2004-12-02
EP1356124B1 (de) 2007-01-24
WO2002061148A2 (en) 2002-08-08
DE60217823D1 (de) 2007-03-15
US20020192642A1 (en) 2002-12-19
WO2002061148A3 (en) 2003-05-15
US6753137B2 (en) 2004-06-22
CN1272448C (zh) 2006-08-30
US20040005551A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
DE60217823D1 (de) Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs
DE69938187D1 (de) Ykl-40 als marker und indikator zur prognose von krebs und detektion von infektionen
CY1106724T1 (el) Εμβαπτιζομενος χαρτης αποξηραμενων αντιδραστηριων και μεθοδος για την ανιχνευση ή και προσδιορισμο ειδικων αλληλουχιων νουκλεϊκων οξεων
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
CA2384579A1 (en) Early cancer tumor marker
AU1038402A (en) Assay for directly detecting a rs virus related biological cell in a body fluid sample
CY1115366T1 (el) Δεικτες ογκου
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
WO2002054067A3 (en) Detection of analytes
DE60030281D1 (de) Methoden zur verbesserung der sensitivität und spezifität von screeningverfahren für krebs und krebs-vorstufen
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
BR0314155A (pt) Métodos para diagnosticar câncer cervical
WO2004007770A3 (en) Method for diagnosis of intestinal-type gastric tumors
DE60110407D1 (de) Reagenz zur bestimmung von blutplättchen-mikroteilchen
ATE317451T1 (de) Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE447713T1 (de) S100-proteine und -autoantikörper als serummarker für krebs
WO2005001141A3 (en) Methods and nucleic acids for analyses of colorectal cell proliferative disorders
WO1998014611A3 (en) Detection and identification of non-polio enteroviruses
WO2006034879A3 (en) Epigenetic methods and nucleic acids for the detection of lung cell proliferative disorders
BR0213997A (pt) Métodos de detecção e identificação de bactérias entéricas
EP1505161A3 (de) Nachweis von Polymorphismen in Epstein-Barr-Virus (EBV) DNA zur Vorhersage und zum Nachweis von EBV-assoziierten Tumoren
WO2005001140A3 (en) Methods and nucleic acids for the analysis of colon cell proliferative disorders
WO2004029216A3 (en) Diagnosis of invasive mold infection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties